Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population

References

• TysonGLEl-SeragHBRisk factors for cholangiocarcinomaHepatology201154117318421488076
   PubMed Web of Science ®Google Scholar
• ShaibYHEl-SeragHBDavilaJAMorganRMcGlynnKARisk factors of intrahepatic cholangiocarcinoma in the United States: a case-control studyGastroenterology2005128362062615765398
   PubMed Web of Science ®Google Scholar
• OhJKWeiderpassEInfection and cancer: global distribution and burden of diseasesAnn Glob Health201480538439225512154
   PubMed Web of Science ®Google Scholar
• JemalABFBrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• PetcharinSPattarawinACancer incidence and leading sitesCancer In Thailand, Vol V; 2001–2003Ministry of Public HealthBangkok2010
   Google Scholar
• ShinHROhJKMasuyerEEpidemiology of cholangiocarcinoma: an update focusing on risk factorsCancer Sci2010101357958520085587
   PubMed Web of Science ®Google Scholar
• SripaBKaewkesSSithithawornPLiver fluke induces cholangiocarcinomaPLoS Med200747e20117622191
   PubMed Web of Science ®Google Scholar
• AndersonCDPinsonCWBerlinJChariRSDiagnosis and treatment of cholangiocarcinomaOncologist2004914357
   PubMed Web of Science ®Google Scholar
• ButthongkomvongKSirachainanEJhankumphaSKumdangSSukhontharotOUTreatment outcome of palliative chemotherapy in inoperable cholangiocarcinoma in ThailandAsian Pac J Cancer Prev20131463565356823886146
   PubMedGoogle Scholar
• RadererMHejnaMHValencakJBTwo consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancerOncology199956317718010202270
   PubMedGoogle Scholar
• PenzMKornekGVRadererMPhase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerAnn Oncol200112218318611300321
   PubMed Web of Science ®Google Scholar
• GlimeliusBHoffmanKSjödénPOChemotherapy improves survival and quality of life in advanced pancreatic and biliary cancerAnn Oncol1996765936008879373
   PubMed Web of Science ®Google Scholar
• FalksonGMacIntyreJMMoertelCGEastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancerCancer19845469659696235908
   PubMedGoogle Scholar
• ChoiCWChoiIKSeoJHEffects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomasAm J Clin Oncol200023442542810955877
   PubMedGoogle Scholar
• ThongprasertSThe role of chemotherapy in cholangiocarcinomaAnn Oncol200516suppl 2ii93ii9615958484
   PubMedGoogle Scholar
• DucreuxMRougierPFandiAEffective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatinAnn Oncol1998966536569681080
   PubMed Web of Science ®Google Scholar
• TaïebJMitryEBoigeVOptimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinomaAnn Oncol20021381192119612181241
   PubMedGoogle Scholar
• ValleJWasanHPalmerDHABC-02 Trial InvestigatorsCisplatin plus gemcitabine versus gemcitabine for biliary tract cancerN Engl J Med2010201036212731281
   Google Scholar
• ValleJWAdvances in the treatment of metastatic or unresectable biliary tract cancerAnn Oncol201021suppl 7vii345vii34820943640
   PubMedGoogle Scholar
• TeradaTAshidaKEndoKc-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinomaHistopathology19983343253319822921
   PubMedGoogle Scholar
• TannapfelABenickeMKatalineAFrequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liverGut200047572172711034592
   PubMed Web of Science ®Google Scholar
• TannapfelASommererFBenickeMMutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinomaGut200352570671212692057
   PubMed Web of Science ®Google Scholar
• AishimaSITaguchiKISugimachiKShimadaMSugimachiKTsuneyoshiMc-erbB-2 and c-Met expression relates to cholangio-carcinogenesis and progression of intrahepatic cholangiocarcinomaHistopathology200240326927811895493
   PubMedGoogle Scholar
• EndoKYoonBIPairojkulCDemetrisAJSiricaAEERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditionsHepatology200236243945012143054
   PubMed Web of Science ®Google Scholar
• RashidAUekiTGaoY-TK-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based Study in ChinaClin Cancer Res20028103156316312374683
   PubMed Web of Science ®Google Scholar
• NakazawaKDobashiYSuzukiSFujiiHTakedaYOoiAAmplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancersJ Pathol2005206335636515892172
   PubMed Web of Science ®Google Scholar
• OoiASuzukiSNakazawaKGene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinomaAnticancer Res2009291192619331129
   PubMedGoogle Scholar
• KawamotoTKrishnamurthySTarcoEHER receptor family: novel candidate for targeted therapy for gallbladder and extrahepatic bile duct cancerGastrointest Cancer Res20071622122719262900
   PubMedGoogle Scholar
• KimHJYooTWParkDIGene amplification and protein over-expression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochem-istry: its prognostic implication in node-positive patientsAnn Oncol200718589289717322545
   PubMed Web of Science ®Google Scholar
• YoshikawaDOjimaHIwasakiMClinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinomaBr J Cancer200898241842518087285
   PubMed Web of Science ®Google Scholar
• HarderJWaizOOttoFEGFR and HER2 expression in advanced biliary tract cancerWorld J Gastroenterol200915364511451719777609
   PubMed Web of Science ®Google Scholar
• HezelAFDeshpandeVZhuAXGenetics of biliary tract cancers and emerging targeted therapiesJ Clin Oncol201028213531354020547994
   PubMed Web of Science ®Google Scholar
• PignochinoYSarottoIPeraldo-NeiaCTargeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomasBMC Cancer20101063121087480
   PubMed Web of Science ®Google Scholar
• ShafizadehNGrenertJPSahaiVKakarSEpidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladderHum Pathol201041448549220040392
   PubMed Web of Science ®Google Scholar
• GuTLDengXHuangFSurvey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinomaPLoS One201161e1564021253578
   PubMed Web of Science ®Google Scholar
• XuRFSunJPZhangSRKRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patientsBiomed Pharmacother2011651222621051183
   PubMed Web of Science ®Google Scholar
• O’DellMRHuangJLWhitney-MillerCLKras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinomaCancer Res20127261557156722266220
   PubMed Web of Science ®Google Scholar
• DaiRLiJFuJThe tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cellsJ Biol Chem201228747398123982323024367
   PubMedGoogle Scholar
• DetarkomSA Pilot Study of Molecular Alterations and the Clinical Prognostic Factors of Cholangiocarcinoma in Thai Population. Ramathibodi Hospital, MahidolEur J Cancer2015512e9
   PubMedGoogle Scholar
• WolffACHammondMEHicksDGAmerican Society of Clinical Oncology; College of American PathologistsRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateJ Clin Oncol201331313997401324101045
   PubMed Web of Science ®Google Scholar
• ZhangBChun-WeiXYunSComparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutationExp Ther Med2015941383138825780439
   PubMedGoogle Scholar
• LeoneFCavalloniGPignochinoYSomatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinomaClin Cancer Res20061261680168516551849
   PubMed Web of Science ®Google Scholar
• ChangYTChangMCHuangKWTungCCHsuCWongJMClinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in TaiwanJ Gastroenterol Hepatol20142951119112524372748
   PubMed Web of Science ®Google Scholar
• GwakGYYoonJHShinCMDetection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomasJ Cancer Res Clin Oncol20051311064965216032426
   PubMed Web of Science ®Google Scholar
• WattanasirichaigoonSTasanakhajornUJesadapatarakulSThe incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction techniqueJ Med Assoc Thai19988153163239623030
   PubMedGoogle Scholar
• VossJSHoltegaardLMKerrSEMolecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisionsHum Pathol20134471216122223391413
   PubMed Web of Science ®Google Scholar
• RienerMOBawohlMClavienPAJochumWRare PIK3CA hotspot mutations in carcinomas of the biliary tractGenes Chromosomes Cancer200847536336718181165
   PubMed Web of Science ®Google Scholar
• ZhaoWZhangBGuoXExpression of Ki-67, Bax and p73 in patients with hilar cholangiocarcinomaCancer Biomark201414419720224934361
   PubMed Web of Science ®Google Scholar
• ZhangHZhengXJiTComparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencingCell Biochem Biophys201262341542022048888
   PubMedGoogle Scholar
• BárbaraAEstherCAnaSGA comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistryPLoS One201278e4384222952784
   PubMedGoogle Scholar
• XuQZhuYBaiYDetection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reactionOnco Targets Ther201581533154126124670
   PubMed Web of Science ®Google Scholar
• OxnardGRPaweletzCPKuangYNoninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNAClin Cancer Res20142061698170524429876
   PubMed Web of Science ®Google Scholar
• HudecovaIDigital PCR analysis of circulating nucleic acidsClin Biochem2015481594895625828047
   PubMed Web of Science ®Google Scholar